Literature DB >> 18811608

Anemia is associated with the progression of white matter disease in older adults with high blood pressure: the cardiovascular health study.

Marco Inzitari1, Stephanie Studenski, Caterina Rosano, Neil A Zakai, William T Longstreth, Mary Cushman, Anne B Newman.   

Abstract

OBJECTIVES: To investigate whether anemia predicts worsening white matter hyperintensities (WMHs) in older community-dwellers.
DESIGN: Prospective cohort study.
SETTING: Older community-dwellers. PARTICIPANTS: One thousand eight hundred forty-six Cardiovascular Health Study (CHS) participants (mean age 73.7 +/- 4.4, 41% male, 15.6% African American). MEASUREMENTS: Participants had hemoglobin measured and brain magnetic resonance imaging (MRI) in 1992/93 and a second brain MRI in 1997/98. Anemia was defined according to World Health Organization criteria (hemoglobin <12 g/dL in women and <13 g/dL in men). Worsening WMHs were determined according to standardized side-by-side readings.
RESULTS: After 5 years, WMHs worsened in 517 participants (28%). Progression was not associated with anemia in the whole sample, in sex or race strata, or in other prespecified subgroups (participants with renal dysfunction or diabetes mellitus), except in participants with high blood pressure (>or=140/90 mmHg). Of the 678 participants with high blood pressure, those with anemia (10.5%) had a 1.79 times greater risk of WMHs worsening (95% confidence interval=1.06-2.98; P for interaction between anemia and high blood pressure=.01) independent of demographics, baseline WMHs, cardiovascular risk factors and comorbidities, medications, renal function, inflammation, and incident stroke (logistic regression models). There was no greater risk in participants with anemia with normal blood pressure.
CONCLUSION: Anemia may contribute to worsening of WMHs in older adults with high blood pressure.

Entities:  

Mesh:

Year:  2008        PMID: 18811608      PMCID: PMC2897005          DOI: 10.1111/j.1532-5415.2008.01950.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  30 in total

1.  Hypertension and cerebral white matter lesions in a prospective cohort study.

Authors:  F-E de Leeuw; J C de Groot; M Oudkerk; J C M Witteman; A Hofman; J van Gijn; M M B Breteler
Journal:  Brain       Date:  2002-04       Impact factor: 13.501

2.  Neuroprotective effect of darbepoetin alfa, a novel recombinant erythropoietic protein, in focal cerebral ischemia in rats.

Authors:  Ludmila Belayev; Larissa Khoutorova; Weizhao Zhao; Alexey Vigdorchik; Andrey Belayev; Raul Busto; Ella Magal; Myron D Ginsberg
Journal:  Stroke       Date:  2005-03-24       Impact factor: 7.914

3.  Erythropoietin therapy for acute stroke is both safe and beneficial.

Authors:  Hannelore Ehrenreich; Martin Hasselblatt; Christoph Dembowski; Lukas Cepek; Piotr Lewczuk; Michael Stiefel; Hans-Heino Rustenbeck; Norbert Breiter; Sonja Jacob; Friederike Knerlich; Matthias Bohn; Wolfgang Poser; Eckart Rüther; Michael Kochen; Olaf Gefeller; Christoph Gleiter; Thomas C Wessel; Marc De Ryck; Loretta Itri; Hilmar Prange; Anthony Cerami; Michael Brines; Anna-Leena Sirén
Journal:  Mol Med       Date:  2002-08       Impact factor: 6.354

4.  Anemia is associated with disability and decreased physical performance and muscle strength in the elderly.

Authors:  Brenda W J H Penninx; Marco Pahor; Matteo Cesari; Anna Maria Corsi; Richard C Woodman; Stephania Bandinelli; Jack M Guralnik; Luigi Ferrucci
Journal:  J Am Geriatr Soc       Date:  2004-05       Impact factor: 5.562

5.  Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study.

Authors:  Jerome L Abramson; Claudine T Jurkovitz; Viola Vaccarino; William S Weintraub; William McClellan
Journal:  Kidney Int       Date:  2003-08       Impact factor: 10.612

6.  Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994).

Authors:  Brad C Astor; Paul Muntner; Adeera Levin; Joseph A Eustace; Josef Coresh
Journal:  Arch Intern Med       Date:  2002-06-24

7.  Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study.

Authors:  W T Longstreth; Corinne Dulberg; Teri A Manolio; Michael R Lewis; Norman J Beauchamp; Daniel O'Leary; Jeff Carr; Curt D Furberg
Journal:  Stroke       Date:  2002-10       Impact factor: 7.914

8.  Anemia and decline in physical performance among older persons.

Authors:  Brenda W J H Penninx; Jack M Guralnik; Graziano Onder; Luigi Ferrucci; Robert B Wallace; Marco Pahor
Journal:  Am J Med       Date:  2003-08-01       Impact factor: 4.965

9.  Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia.

Authors:  Jack M Guralnik; Richard S Eisenstaedt; Luigi Ferrucci; Harvey G Klein; Richard C Woodman
Journal:  Blood       Date:  2004-07-06       Impact factor: 22.113

10.  Cerebrovascular disease and evolution of depressive symptoms in the cardiovascular health study.

Authors:  David C Steffens; K Ranga Rama Krishnan; Casey Crump; Gregory L Burke
Journal:  Stroke       Date:  2002-06       Impact factor: 7.914

View more
  19 in total

1.  Brain structural connectivity in late-life major depressive disorder.

Authors:  Stephen F Smagula; Howard J Aizenstein
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2016-05

2.  Hemoglobin level in older persons and incident Alzheimer disease: prospective cohort analysis.

Authors:  R C Shah; A S Buchman; R S Wilson; S E Leurgans; D A Bennett
Journal:  Neurology       Date:  2011-07-13       Impact factor: 9.910

3.  Prognostic implications of anemia in older adults.

Authors:  Kushang V Patel; Jack M Guralnik
Journal:  Haematologica       Date:  2009-01       Impact factor: 9.941

4.  Long-Term Cognitive Decline After Newly Diagnosed Heart Failure: Longitudinal Analysis in the CHS (Cardiovascular Health Study).

Authors:  Christa A Hammond; Natalie J Blades; Sarwat I Chaudhry; John A Dodson; W T Longstreth; Susan R Heckbert; Bruce M Psaty; Alice M Arnold; Sascha Dublin; Colleen M Sitlani; Julius M Gardin; Stephen M Thielke; Michael G Nanna; Rebecca F Gottesman; Anne B Newman; Evan L Thacker
Journal:  Circ Heart Fail       Date:  2018-03       Impact factor: 8.790

5.  Anemia and risk of dementia in older adults: findings from the Health ABC study.

Authors:  Chang Hyung Hong; Cherie Falvey; Tamara B Harris; Eleanor M Simonsick; Suzanne Satterfield; Luigi Ferrucci; Andrea L Metti; Kushang V Patel; Kristine Yaffe
Journal:  Neurology       Date:  2013-07-31       Impact factor: 9.910

6.  Anemia predicts lower white matter volume and cognitive performance in sickle and non-sickle cell anemia syndrome.

Authors:  Soyoung Choi; Sharon H O'Neil; Anand A Joshi; Jian Li; Adam M Bush; Thomas D Coates; Richard M Leahy; John C Wood
Journal:  Am J Hematol       Date:  2019-07-23       Impact factor: 10.047

7.  Risk factors of vestibular migraine-related brain white matter lesions.

Authors:  Yu Shen; Defu Li; Qian Cao; Mengyao Hu; Zhou Hou; Lijun Xu; Yanping Li; Daojun Hong
Journal:  Acta Neurol Belg       Date:  2022-09-07       Impact factor: 2.471

8.  Hemoglobin decline, function, and mortality in the elderly: the cardiovascular health study.

Authors:  Neil A Zakai; Benjamin French; Alice M Arnold; Anne B Newman; Linda F Fried; John Robbins; Paulo Chaves; Mary Cushman
Journal:  Am J Hematol       Date:  2012-10-09       Impact factor: 10.047

9.  Association of lower hemoglobin level and neuropathology in community-dwelling older persons.

Authors:  Raj C Shah; Julie A Schneider; Sue Leurgans; David A Bennett
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

10.  Reduced global cerebral oxygen metabolic rate in sickle cell disease and chronic anemias.

Authors:  Chau Vu; Adam Bush; Soyoung Choi; Matthew Borzage; Xin Miao; Aart J Nederveen; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2021-05-12       Impact factor: 13.265

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.